What were Calumet's Q2 CY2026 revenue and adjusted EBITDA figures, and how did they compare to expectations?

Calumet reported Q2 CY2026 revenue of $1.45 billion, representing a 40.8% year-on-year increase and significantly beating Wall Street expectations; the company also posted adjusted EBITDA of $175.2 million, exceeding consensus estimates.

Despite a GAAP EPS miss, what key financial improvements did Calumet demonstrate in Q2 CY2026?

Despite a GAAP EPS miss, Calumet demonstrated improved operating margins and generated positive free cash flow of $99.35 million in Q2 CY2026 — a development the news describes as marking a potential inflection point for the company.

ChemBrief

Topics Daily Digest Tags

Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026 Results

Aug 7, 2026

Calumet Specialty Products Partners reported Q2 CY2026 revenue of $1.45 billion, up 40.8% year-on-year, significantly beating Wall Street expectations. The specialty refiner posted adjusted EBITDA of $175.2 million and positive free cash flow of $99.35 million.

StockStory

Calumet (NASDAQ:CLMT) Surprises with Strong Q2 CY2026 Results

FinancialContent

2026-08-07

Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026 Results

2026-08-07

Calumet Specialty Products Partners Reports Second Quarter 2026 Results

2026-08-07

Calumet, Inc. Reports Q2 2026 Earnings Results

2026-08-08

Calumet, Inc. Reports Q2 Revenue $1.45 Billion, Surpassing Estimates